Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Family Medicine
Search Medical Condition
Migraine (Adult) Clinical Trials
A listing of Migraine (Adult) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (27) clinical trials
BHV3000-302: Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy, Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine
BHV-3000 versus placebo in Acute Migraine. The study will recruit male and female patients 18 years of age and older with at least a one-year history of migraines (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders, including an age of onset prior ...
BHV-3000 in Patients with Acute Migraines
People with Acute Migraines are asked to participate in a research study being conducted by Montefiore Medical Center.
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
This study will evaluate the safety and tolerability of the following doses of AGN-241689: 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60 mg BID for the prevention of episodic migraine and will characterize the dose/response relationship.
Efficacy, Tolerability, and Safety of DFN-15
Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine
The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.
Acute Migraines
A research study is evaluating an investigational medication for migraines.
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.
Phase 3 Study to Assess the Safety and Efficacy of ONZETRA (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine in Adolescents
This is a 28 week study requiring a total of 3 clinic visits. Subjects will be treated with either a placebo or the study drug which is given intranasally.
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine.
This is a Prospective, Randomized, Vehicle‐controlled, Double‐blind, Multi-center, 3-arm study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray for preventive treatment in subjects with episodic migraine.
Migraine Headache Study
Doctors are Testing an Investigational Product for Preventing Migraines STOP 301 is a new clinical research study that is looking for people who suffer from migraine headaches to test an investigational drug device product. This product is a nasal spray that’s used when you have a migraine attack. (“Investigational” means ...
